Comparing osteoporosis treatments fairly means comparing them on four things: what each one does to bone density, what it does to fracture risk, how long you use it, and what it costs you in side effects. Antiresorptives (bisphosphonates, Prolia) protect the bone you have. Anabolics (Forteo, Tymlos, Evenity) build the most new bone of any drug class over a short course. HRT preserves density around menopause for the right candidate. Osteogenic loading delivers the mechanical signal no medication supplies, with no drug side effects, and nutrition supplies the raw materials. No single option wins every column, which is why the strongest plans pair a physician-directed medical decision with weekly osteogenic loading at OsteoStrong.
Why comparing osteoporosis treatments is harder than it looks
You probably arrived here with a DEXA report in one hand and a drug name in the other. Comparing osteoporosis treatments feels like it should be simple: line them up, pick the biggest number. But each option is good at a different job, and the job that matters most depends on where your bones are today.
We keep a plain-language page on every osteoporosis treatment option available in Austin, including the local specialists who prescribe them, and a post that answers the either/or question of medication vs. exercise and diet. This article is narrower: one matrix, every major approach, column by column.
What "works best" has to mean
Before any comparison is fair, you need a scoreboard. Five columns matter:
- Bone density. Your T-score on the next DEXA.
- Fracture risk. The outcome that changes your life. The Bone Health and Osteoporosis Foundation (BHOF) estimates about 1 in 2 women over 50 will break a bone because of osteoporosis.
- Duration. Fixed course, indefinite, or dangerous to end abruptly.
- Side effects. Common and mild, rare and serious.
- What it cannot do. The blind spot decides what to pair it with.
Comparing osteoporosis treatments side by side
| Treatment | Bone density | Fracture risk | Typical duration | Main side effects | What it cannot do |
|---|---|---|---|---|---|
| Bisphosphonates (Fosamax, Actonel, Boniva, Reclast) | Slows loss; modest gains as remodeling spaces fill | Fewer spine fractures; fewer hip fractures in established osteoporosis | Often 3 to 5 years, then reassessment (drug holiday) | Oral forms can irritate the esophagus; rare jaw osteonecrosis and atypical femur fracture | Builds little new bone; nothing for balance or muscle |
| Denosumab (Prolia) | Slows loss; density rises while on it | Fewer spine, hip, and other fractures | Every 6 months, until a planned transition | Rare jaw osteonecrosis and atypical fracture; rebound loss and vertebral fractures if stopped without follow-on therapy | Never stop without a physician exit plan; no mechanical signal |
| Anabolics (Forteo, Tymlos, Evenity) | Largest gains of any drug class, mostly spine | Fewer spine and other fractures in high-risk women | About 2 years (Forteo, Tymlos); 12 monthly doses (Evenity); then an antiresorptive | Daily injections; dizziness, nausea; Evenity carries a cardiovascular warning | Gains fade without follow-on therapy; reserved for higher risk |
| Hormone therapy (HRT) | Preserves density, most when started near menopause | FDA-approved for prevention; fewer fractures in the Women's Health Initiative | Individual; benefit-risk shifts with age and time since menopause | Breast tenderness, bleeding; clot, stroke, and breast cancer risk depend on age and history | Not for every history; protection ends when therapy ends |
| Osteogenic loading (OsteoStrong) | 14.9% hip and 16.6% spine over about 30 months (Hunte et al., Journal of Osteoporosis) | Raises femoral neck density and trains the strength and balance that prevent the fall | About 15 minutes once a week, ongoing | No drug interactions, no impact; early muscle soreness | Does not change bone chemistry; does not replace a prescription your physician judges necessary |
| Conventional exercise (walking, light weights, yoga) | Maintains more than builds | Lowers fall risk when it includes balance and strength work | Ongoing | Low; injury risk rises with heavier loads and poor form | Rarely reaches roughly 4.2 times body weight, the load bone responds to |
| Nutrition (calcium, vitamin D, protein) | Prevents deficiency-driven loss; does not build bone alone | Vitamin D and protein support muscle and balance | Ongoing | Calcium pills: constipation, kidney stones in some; vitamin D toxic above 4,000 IU daily | Raw materials without a signal do not become bone |
Medication columns come from prescribing information and BHOF guidance and are kept qualitative on purpose, because your own risk reduction depends on your baseline, age, and consistency. The loading figures come from a published study and from our members' follow-up DEXAs, which are performed by independent imaging providers, never by us.
Which osteoporosis treatment builds the most bone density?
Per course, the anabolic drugs. Teriparatide, abaloparatide, and romosozumab turn on the cells that lay down new bone, and over one to two years they produce the largest spine gains in the pharmaceutical toolkit. That is why physicians reserve them for women with a prior fragility fracture, very low T-scores, or a FRAX score above the U.S. treatment thresholds of 20% for major osteoporotic fracture and 3% for hip fracture. When the course ends, a physician almost always follows with an antiresorptive, because the new bone needs guarding.
Antiresorptives sit at the other end. Alendronate, risedronate, zoledronic acid, and denosumab slow the removal crew; density rises modestly as remodeling spaces fill, then holds.
Osteogenic loading works on a different axis. Bone adapts to strain, and the research threshold for that adaptation is roughly 4.2 times body weight (Deere et al., 2012). Loading at that level once a week, in your strongest range of motion, is the input the drugs do not supply. Hunte et al. measured 14.9% at the hip and 16.6% at the spine over about 30 months in postmenopausal women. Among our own members who follow the weekly protocol and complete a follow-up DEXA, 8 out of 10 see measurable improvement; the biggest factors are consistency and starting point. Kathleen, an Austin member in her 60s, saw both her spine and her hip move from osteoporosis to normal, which you can read in full in her case study.
Which treatment lowers fracture risk the most?
A fracture needs two things: a bone weak enough to break, and a force strong enough to break it. Most hip fractures start with a fall, and the CDC reports that about 1 in 3 adults over 65 falls each year.
Medications work on the first half: bisphosphonates, denosumab, and the anabolics all reduce fracture rates in trials by making bone harder to break. None of them touch the second half. A woman on Prolia who trips on a curb falls exactly as hard as she did before the injection.
Osteogenic loading works on both halves. It raises density at the femoral neck, the site FRAX weights most heavily, and because you produce force through your legs, hips, and trunk every session, strength and reaction time rise with it. Our members describe catching themselves on stairs that would have put them on the floor a year earlier; several tell it on camera on our results page. That is why fall prevention and balance training is part of bone health for us, not a separate topic.
What each osteoporosis treatment cannot do
The blind spots decide the pairings:
- Bisphosphonates and Prolia cannot build meaningful new bone or train your balance. Pair them with loading.
- Anabolics cannot hold their gains alone. They need a follow-on antiresorptive and a mechanical signal that keeps telling the new bone it is needed.
- HRT cannot protect bone after you stop it. Load while you are on it, and keep loading after.
- Osteogenic loading cannot alter bone chemistry. If your physician judges that your fracture risk calls for a prescription, loading is the addition, not the substitute.
- Walking and ordinary exercise cannot reach the loading threshold. Keep them for heart, mood, and fall prevention.
- Calcium, vitamin D, and protein cannot become bone without a signal telling the body where to put them. Food first, at the NIH Office of Dietary Supplements targets (1,200 mg calcium daily for women 51 and up, 600 to 800 IU vitamin D), then add load.
What this looks like at OsteoStrong
A session at our Austin or Georgetown center takes about 15 minutes, once a week, in street clothes. You work through four devices with a coach beside you, producing force against the device rather than lifting a weight, so there is no impact and no bar to control. Force output is measured every session, so you see the number climb week over week, long before the next DEXA.
It keeps working because of Frost's mechanostat: as bone gets stronger, a fixed load produces less strain, so the stimulus has to keep rising. Our coaches progress you in very small joint-angle increments inside your strongest range of motion, which keeps the load above threshold in a way a barbell, capped by the weakest point in the lift, cannot. Our session protocols are reviewed on an ongoing basis with the physicians who refer to us, and more than 100 Austin-area physicians do. The full mechanism is in how OsteoStrong works.
OsteoStrong sits alongside your physician's plan, never instead of it. Members on alendronate, Prolia, Forteo, and HRT all train with us. If you are on Prolia, keep every six-month appointment; it must never be stopped without a physician's exit plan.
So which osteoporosis treatment is best for you?
Match the plan to the starting point:
- Prior fragility fracture, T-score well below -2.5, or FRAX above threshold. Your physician will likely recommend medication. Add osteogenic loading from week one so the mechanical side is covered.
- Osteopenia (T-score between -1.0 and -2.5) with a low FRAX. Many physicians will watch and re-scan. Make it active watching: loading, protein, vitamin D, balance work, and a scheduled follow-up DEXA. Our osteopenia support page lays out that plan.
- Already on a medication. Stay on it, ask what it is expected to do to your T-score by the next scan, then add the signal it cannot deliver.
- Cannot or prefer not to take medication. Say so, and ask what a safe non-drug plan must include. Our page on osteoporosis treatment without medication walks through the four pillars.
Every path has the same footnote: the medication decision belongs to you and your physician.
The bottom line
No osteoporosis treatment wins every column. Drugs change chemistry, loading changes the signal, and nutrition supplies the materials, so the answer to "which works best" is "the combination that fits your starting point." Anabolics build the most bone per course, antiresorptives protect what you have, HRT helps the right candidate, and osteogenic loading raises density, strength, and balance at once with no drug interactions. Build the plan with your physician, and make sure the mechanical column is not blank.
Want to know where osteogenic loading fits in your plan? Book a free Bone Health Roadmap Call, bring your DEXA and your medication list, and we will walk through the comparison for your specific numbers.
This article is for general education and is not medical advice. Talk to your own doctor before starting, stopping, or changing any medication, supplement, or exercise program, especially if you have a diagnosis of osteopenia or osteoporosis.
Your simple plan from here
- Book your free Bone Health Call. 15 minutes, phone or Zoom, no pressure.
- Come in for a guided first session. A coach walks you through all four devices.
- Track your strength week after week. 15 minutes, once a week. The numbers rise.
Frequently asked questions
When comparing osteoporosis treatments, which one works best?
It depends on your starting point. Anabolic drugs (Forteo, Tymlos, Evenity) build the most bone per course and are reserved for higher-risk women. Bisphosphonates and Prolia protect the bone you have. Osteogenic loading delivers the mechanical signal none of the drugs supply and trains the strength and balance that prevent falls. When comparing osteoporosis treatments, the plans that combine a physician-directed medical decision with weekly loading and solid nutrition outperform any single option.
What is the difference between antiresorptive and anabolic osteoporosis drugs?
Antiresorptives (alendronate, risedronate, zoledronic acid, denosumab) slow the osteoclasts that remove old bone, so density holds or rises modestly. Anabolics (teriparatide, abaloparatide, romosozumab) stimulate the osteoblasts that build new bone and produce larger gains over a fixed course of about one to two years, after which a physician normally prescribes an antiresorptive to lock in the gains.
Does exercise work as well as medication for osteoporosis?
Ordinary exercise such as walking, swimming, or light weights rarely reaches the load that triggers new bone, which research places at roughly 4.2 times body weight (Deere et al.). Osteogenic loading is designed to reach that threshold safely in about 15 minutes a week. Medication and mechanical loading work on different pathways, chemistry versus strain, so the useful question is not which replaces the other but how they combine.
Can osteogenic loading replace my osteoporosis medication?
That decision belongs to you and your physician, never to us. Osteogenic loading works alongside every osteoporosis medication because it delivers a mechanical signal rather than a chemical one, which is why more than 100 Austin-area physicians refer patients to OsteoStrong while those patients stay on their prescriptions. If you take Prolia, never let it lapse without a physician exit plan, because rebound bone loss is well documented. Read more about how OsteoStrong fits alongside treatment in Austin.
How do I know whether my osteoporosis treatment is working?
The only proof is a follow-up DEXA on the same machine, usually 12 to 24 months after your baseline, showing a change larger than the scanner's least significant change (typically around 3 to 5 percent). Between scans you can watch the markers that move first: measured force output, single-leg balance time, and grip strength. Ask your physician what your specific treatment is expected to do to your T-score, and by when, so the next scan has a benchmark.
Is HRT a good osteoporosis treatment?
Hormone therapy is FDA-approved for prevention of postmenopausal osteoporosis and preserves bone density, especially when started closer to menopause. Its benefit-risk balance is individual and depends on your age, years since menopause, and breast cancer and clot history, so it is a conversation with your physician rather than a general recommendation. Bone protection from HRT ends when the therapy ends, which is one reason to pair it with loading.


